Israel suspends sales of anti-cancer medication after new study

Israel’s health ministry has suspended sales of some anti-aging products after a new study showed they contained high levels of ingredients that can cause cancer.

The ministry said Wednesday that the products sold in the market include anti-inflammatory medication and skincaria, a skin-care product.

Some products were sold without a prescription.

Israel’s Health Ministry said it will review the products for the safety of consumers.

It said the new study was not connected to the ban.

A report by the Israeli Food Safety Authority (IFA) on January 31 found that several anti-inflammatories sold in Israel contain potentially carcinogenic ingredients.

Israel banned sales of the products in April after the IFA said that one product contained chemicals linked to breast cancer.